Extensively drug-resistant tuberculosis, Italy and Germany

Giovanni Battista Migliori et al. Emerg Infect Dis.2007 May.

.2007 May;13(5):780-2.

doi: 10.3201/eid1305.070200.

No abstract available

References

1. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC. 125 years after Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic? Eur Respir J. 2007;29:423–7. 10.1183/09031936.00001307 - DOI - PubMed
1. Laszlo A, Rahman M, Espinal M, Raviglione M; WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing ofMycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: five rounds of proficiency testing 1994–1998. Int J Tuberc Lung Dis. 2002;6:748–56. - PubMed
1. World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec. 2006;81:430–2. - PubMed
1. Shah NS, Wright A, Bai G-H, Barrera L, Boulahbal F, Martín-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13:380–7. - PMC - PubMed
1. Ferrara G, Richeldi L, Bugiani M, Cirillo D, Besozzi G, Nutini S, et al. Management of multidrug-resistant tuberculosis in Italy. Int J Tuberc Lung Dis. 2005;9:507–13. - PubMed